Editas Medicine, Inc. EDIT
2.57 USD +0.02 (+0.78%)
At closeNov 6, 2026, 6:37 PM EST
2.57 0.00 0.00%
After hours · Nov 6, 6:37 PM ET
2.48 Day range 2.63
1.66 52-week range 3.75
- YTD
- +25.37%
- 1 year
- -4.46%
EDIT revenue history
Revenue is income from the company’s ordinary business activities.
40,520,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 40,520,000 | 8,206,000 | 25.39% |
| FY 2024 | 2024-12-31 | 32,314,000 | -45,809,000 | -58.64% |
| FY 2023 | 2023-12-31 | 78,123,000 | 58,411,000 | 296.32% |
| FY 2022 | 2022-12-31 | 19,712,000 | -5,832,000 | -22.83% |
| FY 2021 | 2021-12-31 | 25,544,000 | -65,188,000 | -71.85% |
| FY 2020 | 2020-12-31 | 90,732,000 | 70,201,000 | 341.93% |
| FY 2019 | 2019-12-31 | 20,531,000 | -11,406,000 | -35.71% |
| FY 2018 | 2018-12-31 | 31,937,000 | 18,209,000 | 132.64% |
| FY 2017 | 2017-12-31 | 13,728,000 | 7,675,000 | 126.80% |
| FY 2016 | 2016-12-31 | 6,053,000 | 4,424,000 | 271.58% |
| FY 2015 | 2015-12-31 | 1,629,000 | 1,629,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:20.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.